Abstract
The Greater Mekong subregion is a recurrent source of antimalarial drug resistance in Plasmodium falciparum malaria. This study aimed to characterise the extent and spread of resistance across this entire region between 2007 and 2018. P falciparum isolates from Myanmar, Thailand, Laos, and Cambodia were obtained from clinical trials and epidemiological studies done between Jan 1, 2007, and Dec 31, 2018, and were genotyped for molecular markers (pfkelch, pfcrt, pfplasmepsin2, and pfmdr1) of antimalarial drug resistance. Genetic relatedness was assessed using microsatellite and single nucleotide polymorphism typing of flanking sequences around target genes. 10 632 isolates were genotyped. A single long pfkelch Cys580Tyr haplotype (from -50 kb to +31·5 kb) conferring artemisinin resistance (PfPailin) now dominates across the eastern Greater Mekong subregion. Piperaquine resistance associated with pfplasmepsin2 gene amplification and mutations in pfcrt downstream of the Lys76Thr chloroquine resistance locus has also developed. On the Thailand-Myanmar border a different pfkelch Cys580Tyr lineage rose to high frequencies before it was eliminated. Elsewhere in Myanmar the Cys580Tyr allele remains widespread at low allele frequencies. ...Continue Reading
Citations
Jul 14, 2020·British Journal of Clinical Pharmacology·Borimas Hanboonkunupakarn, Nicholas J White
Nov 12, 2020·MBio·Nelson V SimwelaAndrew P Waters
Dec 3, 2020·MBio·Carla CalçadaMaria Isabel Veiga
Nov 4, 2020·Antimicrobial Agents and Chemotherapy·Kathrin WitmerJake Baum
Nov 5, 2020·The American Journal of Tropical Medicine and Hygiene·Fatema Tuj JohoraMohammad Shafiul Alam
Feb 11, 2021·Journal of Natural Products·Jin Woo LeeRobert H Cichewicz
Jan 22, 2021·Malaria Journal·Amber KunkelPatrice Piola
Oct 17, 2020·Trends in Parasitology·Rob W van der PluijmArjen M Dondorp
Mar 1, 2021·Malaria Journal·Suttipat SrisuthamMallika Imwong
May 11, 2021·ACS Infectious Diseases·Melissa R Rosenthal, Caroline L Ng
Jun 6, 2021·International Journal for Parasitology. Drugs and Drug Resistance·Faiza Amber SiddiquiLiwang Cui
Jun 11, 2021·Malaria Journal·Prayuth SudathipJui A Shah
Jun 11, 2021·BMC Medicine·Makoto SaitoRose McGready
Jun 11, 2021·Tropical Medicine and Health·Kay Thwe HanJetsumon Sattabongkot
Jun 21, 2021·The Lancet Infectious Diseases·Alistair R D McLeanFrank M Smithuis
Jun 30, 2021·Scientific Reports·Nonlawat BoonyalaiJariyanart Gaywee
Jul 2, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Katharina LastUNKNOWN Trainee Association of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Jul 23, 2021·Science Translational Medicine·James M MurithiDidier Leroy
Jul 20, 2021·ELife·Barbara H StokesDavid A Fidock
Jul 28, 2021·Expert Opinion on Pharmacotherapy·Erik KoehneAndrea Kreidenweiss
Aug 13, 2021·ELife·Colin Sutherland, Didier Menard
Aug 15, 2021·BMJ Open·Win Han OoFreya J I Fowkes
Jul 17, 2021·Current Opinion in Infectious Diseases·Mehul DhordaArjen M Dondorp
Oct 15, 2021·Malaria Journal·Christian Nsanzabana
Sep 14, 2021·Antimicrobial Agents and Chemotherapy·Mallika ImwongArjen M Dondorp
Nov 15, 2021·Biochemical Pharmacology·Toshihiro MitaYuzuru Kubohara